SCIENCES, INC. GILEAD, a 10% owner of $ASMB ($ASMB), bought 940,499 shares of the company on 12-19-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately 74.1%. Following this trade, they now own 2,209,471 shares of $ASMB stock.
$ASMB Insider Trading Activity
$ASMB insiders have traded $ASMB stock on the open market 12 times in the past 6 months. Of those trades, 7 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ASMB stock by insiders over the last 6 months:
- SCIENCES, INC. GILEAD purchased 940,499 shares.
- ALEXANDER SCHORNSTEIN has traded it 6 times. They made 6 purchases, buying 44,000 shares and 0 sales.
- NICOLE S WHITE (Chief Manufacturing Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 982 shares.
- JASON A OKAZAKI (CEO and President) has traded it 2 times. They made 0 purchases and 2 sales, selling 1,178 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ASMB Hedge Fund Activity
We have seen 12 institutional investors add shares of $ASMB stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC removed 114,000 shares (-24.4%) from their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 85,905 shares (-69.6%) from their portfolio in Q3 2024
- NORTHERN TRUST CORP added 18,257 shares (+157.8%) to their portfolio in Q3 2024
- MARSHALL WACE, LLP added 12,725 shares (+inf%) to their portfolio in Q3 2024
- ACUITAS INVESTMENTS, LLC added 12,319 shares (+24.6%) to their portfolio in Q3 2024
- RENAISSANCE TECHNOLOGIES LLC added 10,713 shares (+19.5%) to their portfolio in Q3 2024
- GEODE CAPITAL MANAGEMENT, LLC removed 7,375 shares (-13.6%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
